From Leaky Gut to Central Nervous System Autoimmunity: Cross-Reactivity and Molecular Mimicry in Schizophrenia
DOI:
https://doi.org/10.12775/QS.2026.57.72570Keywords
schizophrenia, molecular mimicry, dysbiosis, gut-brain axis, autoimmunityAbstract
Background and Aim: Traditional schizophrenia models relying on neurotransmitter dysfunctions are giving way to new perspectives. Stepping beyond the conventional gut-brain axis paradigm, this review emphasizes a fresh autoimmune hypothesis: molecular mimicry and cascading tissue barrier breakdowns as direct triggers of central nervous system (CNS) pathology.
Materials and Methods: We analyze recent clinical studies concerning intestinal and blood-brain barrier (BBB) integrity, focusing on specific mechanisms: the kynurenine pathway, cross-reactivity to food antigens (wheat gluten, bovine casein), and NMDA receptor autoantibodies in schizophrenia.
Results: Schizophrenia-associated dysbiosis, marked by a depletion of butyrate-producing bacteria, compromises the intestinal barrier, leading to metabolic endotoxemia. Crucially, the pathology is driven by immune deception. Given the structural homologies between foreign or dietary antigens and host tissues (molecular mimicry), cross-reactive lymphocytes and autoantibodies are generated. These penetrate the compromised BBB - sometimes via a macrophage-mediated "Trojan Horse" mechanism - and directly attack host brain structures, including myelin and NMDA receptors. Concurrently, systemic inflammation pathologically redirects tryptophan metabolism, producing neurotoxic kynurenic acid.
Conclusions: Schizophrenia's pathophysiology is inextricably linked to immune autoaggression initiated by molecular mimicry. Shifting focus from general microbiome presence to the mechanisms of cross-reactivity and cascading barrier hyperpermeability reveals novel avenues for antigen-specific therapies. Addressing these root causes offers substantial hope for profound clinical improvement or even full remission.
References
[1] Dąbrowska, J., Wójcik, M., Szarpak, J., et al. (2020). Theories of the pathogenesis of schizophrenia. Journal of Education, Health and Sport, 10(8), 333-335. https://doi.org/10.12775/JEHS.2020.10.08.039
[2] Gronholm, P., Ali, S., Brohan, E., & Thornicroft, G. (2023). Discrimination reported by people with schizophrenia: cross-national variations in relation to the Human Development Index. Epidemiology and Psychiatric Sciences, 32 (e66). https://doi.org/10.1017/S2045796023000781
[3] Brzuszkiewicz, K., Rudziński, G., Łozowski, B., et al. (2023). The role of environmental factors in the etiology of schizophrenia. Journal of Education, Health and Sport, 23(1), 52. https://doi.org/10.12775/JEHS.2023.23.01.006
[4] Madoń, J., Czechowicz, M., & Gadziński, P. (2025). The role of autoimmune processes in the course of mental illness - a review of the most important immunological markers and therapeutic perspectives. Journal of Education, Health and Sport, 86. https://doi.org/10.12775/JEHS.2025.86.67336
[5] Jakubiak, A., Karaban, Ł., Borawski, M., et al. (2025). Dysbiosis and Schizophrenia: A Review of Current Evidence on the Gut–Brain Axis and Probiotic Interventions. Quality in Sport, 41(2025). https://doi.org/10.12775/QS.2025.41.60353
[6] Bravo, J. A., Forsythe, P., Chew, M. V., et al. (2011). Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. PNAS, 108(38), 16050. https://doi.org/10.1073/pnas.1102999108
[7] Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., et al. (2019). The Microbiota-Gut-Brain Axis. Physiological Reviews, 99(4), 1880. https://doi.org/10.1152/physrev.00018.2018
[8] Obrenovich, M. E. M. (2018). Leaky Gut, Leaky Brain? Microorganisms, 6(4). https://doi.org/10.3390/microorganisms6040107
[9] Giron, M. C., Baj, A., & Giaroni, C. (2022). Editorial: Neuroendocrine signalling pathways along the microbiota-gut-brain axis in functional gut disorders. Frontiers in Endocrinology, 13. https://doi.org/10.3389/fendo.2022.996382
[10] Daneman, R., & Rescigno, M. (2009). The Gut Immune Barrier and the Blood-Brain Barrier: Are They So Different? Immunity, 31(5), 722-723. https://doi.org/10.1016/j.immuni.2009.09.012
[11] Li, Z., Tao, X., Wang, D., et al. (2024). Alterations of the gut microbiota in patients with schizophrenia. Frontiers in Psychiatry, 15. https://doi.org/10.3389/fpsyt.2024.1366311
[12] Czachajda, M., Góral, A., Duszyńska, K., et al. (2024). Short-chain fatty acids and their impact on human health– a review. Medycyna Ogólna i Nauki o Zdrowiu, 30(3), 181. https://doi.org/10.26444/monz/190750
[13] Andrzej, A., Nowakowski, J., & Dudek, D. (2016). Interactions between the gut microbiome and the central nervous system and their role in schizophrenia, bipolar disorder and depression. Archives of Psychiatry and Psychotherapy, 18(4). https://doi.org/10.12740/APP/62962
[14] Zheng, P., Zeng, B., Liu, M., et al. (2019). The gut microbiome from patients with schizophrenia modulates the glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviors in mice. Science Advances, 5(2), 1-3. https://doi.org/10.1126/sciadv.aau8317
[15] Lee, B., Moon, K. M., & Kim, C. Y. (2018). Tight Junction in the Intestinal Epithelium: Its Association with Diseases and Regulation by Phytochemicals. Journal of Immunology Research, 2018(1), 1-3. https://doi.org/10.1155/2018/2645465
[16] Bischoff, S. C., Barbara, G., Buurman, W., et al. (2014). Intestinal permeability – a new target for disease prevention and therapy. BMC Gastroenterology, 14(1). https://doi.org/10.1186/s12876-014-0189-7
[17] Papacocea, R.-I., Iliută, F. P., & Papacocea, I. R. (2026). Gut Microbiome Dysregulation Across Schizophrenia Spectrum Disorders: Bacteria-, Fungi- and Virome-Level Alterations with Molecular and Immunological Implications. International Journal of Molecular Sciences, 27(8). https://doi.org/10.3390/ijms27083372
[18] Vargas-Caraveo, A., & Martínez-Martínez, A. (2025). Beyond metabolic endotoxemia paradigm: The circulating lipopolysaccharidome as a determinant of low-grade inflammation and immunomodulation. Medical Hypotheses, 206. https://doi.org/10.1016/j.mehy.2025.111847
[19] Pączek, A. J., Kowalczyk, A., Staniszewska, W., et al. (2025). Gut Microbiota and Its Role in Obesity and Metabolic Syndrome: A Narrative Review. Journal of Education, Health and Sport, 85(2025). https://doi.org/10.12775/JEHS.2025.85.66499
[20] Braniste, V., Al-Asmakh, M., Kowal, C., et al. (2014). The gut microbiota influences blood-brain barrier permeability in mice. Science Translational Medicine, 6(263). https://doi.org/10.1126/scitranslmed.3009759
[21] Palma, M. (2021). Bacterial molecular mimicry in autoimmune diseases. Current Bioscience, 1(1). https://doi.org/10.51959/cb.2021.v1n1.e01
[22] Suliman, B. A. (2024). Potential clinical implications of molecular mimicry-induced autoimmunity. Immunity, Inflammation and Disease, 12(1). https://doi.org/10.1002/iid3.1178
[23] De Jong, H., Wösten, M. M. S. M., & Wennekes, T. (2021). Sweet impersonators: Molecular mimicry of host glycans by bacteria. Glycobiology, 32(1). https://doi.org/10.1093/glycob/cwab104
[24] Balu, D. T. (2016). The NMDA Receptor and Schizophrenia: From Pathophysiology to Treatment. Advances in Pharmacology, 76. https://doi.org/10.1016/bs.apha.2016.01.006
[25] Beck, K., Lally, J., Shergill, S. S., et al. (2015). Prevalence of serum N-methyl-d-aspartate receptor autoantibodies in refractory psychosis. The British Journal of Psychiatry, 206(2), 164-165. https://doi.org/10.1192/bjp.bp.113.142216
[26] Iqbal, A., Bokhari, S. F. H., Rehman, M. U., et al. (2025). Gut-brain connection in schizophrenia: A narrative review. World Journal of Psychiatry, 15(5). http://dx.doi.org/10.5498/wjp.v15.i5.103751
[27] Li, M., Wu, Y., Xu, Y., et al. (2025). Peripheral tryptophan-kynurenine pathway dysfunction in first-episode schizophrenia. Scientific Reports, 15(1). https://doi.org/10.1038/s41598-025-86390-4
[28] Plitman, E., Iwata, Y., Caravaggio, F., et al. (2017). Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis. Schizophrenia Bulletin, 43(4) 764-765. https://doi.org/10.1093/schbul/sbw221
[29] Hatzimanolis, A., Foteli, S., Xenaki, L.-A., et al. (2024). Elevated serum kynurenic acid in individuals with first-episode psychosis and insufficient response to antipsychotics. Schizophrenia, 10(1). https://doi.org/10.1038/s41537-024-00483-z
[30] Severance, E. G., Alaedini, A., Yang, S., et al. (2012). Gastrointestinal inflammation and associated immune activation in schizophrenia. Schizophrenia Research, 138(1), 48-53. https://doi.org/10.1016/j.schres.2012.02.025
[31] Karakuła-Juchnowicz, H., Dzikowski, M., Pelczarska, A., et al. (2016). The brain-gut axis dysfunctions and hypersensitivity to food antigens in the etiopathogenesis of schizophrenia. Psychiatria Polska, 50(4), 755. http://dx.doi.org/10.12740/PP/OnlineFirst/45053
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Nina Nowicka, Emil Mian, Zuzanna Zapart, Alicja Sikorska, Martyna Szepietowska, Oliwia Zuzanna Gańska, Jakub Bundyra, Dominika Janik, Agata Sochocka, Julia Parda
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 6
Number of citations: 0
